GL
RNAM

Governors Lane’s Avidity Biosciences RNAM Stock Holding History

Governors Lane’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-122,733
Closed -$8.85M – 214
2025
Q4 		$8.85M Buy
+122,733
New +$7.93M 0.52% 50

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Governors Lane's RNAM Position: Q1 2026 in Review

Governors Lane sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 122,733 shares — an estimated $8.85M sold.

Governors Lane first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $8.85M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Governors Lane reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Governors Lane sold 122,733 Avidity Biosciences shares in Q1 2026, an estimated $8.85M.
  • Governors Lane first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Governors Lane's Avidity Biosciences position peaked at $8.85M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Governors Lane's 13F filing for Q1 2026, filed 15 May 2026.